Login to Your Account

Pharma: Other news to note

Tuesday, February 18, 2014
Mayne Pharma USA, of Greenville, N.C., has agreed to acquire the headache drugs Esgic (butalbital, acetaminophen, and caffeine) and Esgic Plus (butalbital, acetaminophen, and caffeine), as well as Lorcet (hydrocodone bitartrate and acetaminophen) and Lorcet Plus brands, for pain, and related assets from Forest Laboratories Inc., of New York, for $12 million.

To continue reading subscribe now to BioWorld Today

Learn More about BioWorld Today

Already a subscriber? Sign In or Buy now to activate your subscription